Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2001 2
2002 5
2003 4
2004 10
2005 5
2006 1
2007 4
2008 3
2009 10
2010 18
2011 17
2012 15
2013 20
2014 19
2015 16
2016 13
2017 10
2018 5
2019 12
2020 6
2021 3
2022 2
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Results by year

Filters applied: . Clear all
Page 1
Rifaximin treatment in hepatic encephalopathy.
Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S, Sheikh MY, Beavers K, Frederick T, Teperman L, Hillebrand D, Huang S, Merchant K, Shaw A, Bortey E, Forbes WP. Bass NM, et al. Among authors: poordad f. N Engl J Med. 2010 Mar 25;362(12):1071-81. doi: 10.1056/NEJMoa0907893. N Engl J Med. 2010. PMID: 20335583 Free article. Clinical Trial.
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial.
Ratziu V, de Guevara L, Safadi R, Poordad F, Fuster F, Flores-Figueroa J, Arrese M, Fracanzani AL, Ben Bashat D, Lackner K, Gorfine T, Kadosh S, Oren R, Halperin M, Hayardeny L, Loomba R, Friedman S; ARREST investigator study group; Sanyal AJ. Ratziu V, et al. Among authors: poordad f. Nat Med. 2021 Oct;27(10):1825-1835. doi: 10.1038/s41591-021-01495-3. Epub 2021 Oct 7. Nat Med. 2021. PMID: 34621052 Free article. Clinical Trial.
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, Romero-Gomez M, Boursier J, Abdelmalek M, Caldwell S, Drenth J, Anstee QM, Hum D, Hanf R, Roudot A, Megnien S, Staels B, Sanyal A; GOLDEN-505 Investigator Study Group. Ratziu V, et al. Gastroenterology. 2016 May;150(5):1147-1159.e5. doi: 10.1053/j.gastro.2016.01.038. Epub 2016 Feb 11. Gastroenterology. 2016. PMID: 26874076 Free article. Clinical Trial.
Hepatic encephalopathy.
Khungar V, Poordad F. Khungar V, et al. Among authors: poordad f. Clin Liver Dis. 2012 May;16(2):301-20. doi: 10.1016/j.cld.2012.03.009. Clin Liver Dis. 2012. PMID: 22541700 Review.
Preface.
Poordad F. Poordad F. Clin Liver Dis. 2011 Aug;15(3):xiii-xiv. doi: 10.1016/j.cld.2011.06.001. Clin Liver Dis. 2011. PMID: 21867930 No abstract available.
Management of overt hepatic encephalopathy.
Khungar V, Poordad F. Khungar V, et al. Among authors: poordad f. Clin Liver Dis. 2012 Feb;16(1):73-89. doi: 10.1016/j.cld.2011.12.007. Clin Liver Dis. 2012. PMID: 22321466 Review.
Imatinib (Gleevec)-induced hepatotoxicity.
Ayoub WS, Geller SA, Tran T, Martin P, Vierling JM, Poordad FF. Ayoub WS, et al. Among authors: poordad ff. J Clin Gastroenterol. 2005 Jan;39(1):75-7. J Clin Gastroenterol. 2005. PMID: 15599217
182 results